Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study

被引:345
作者
Zhang, Yue-Xi [1 ]
Zhou, Li-Ya [2 ]
Song, Zhi-Qiang [2 ]
Zhang, Jian-Zhong [3 ]
He, Li-Hua [3 ]
Ding, Yu [2 ]
机构
[1] Beijing Sixth Hosp, Dept Gastroenterol, Beijing 100007, Peoples R China
[2] Peking Univ, Hosp 3, Dept Gastroenterol, Beijing 100191, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China
关键词
Helicobacter pylori; Antibiotic resistance; Beijing; Dyspeptic symptoms; STANDARD TRIPLE THERAPY; SEQUENTIAL THERAPY; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; ERADICATION; AMOXICILLIN; MULTICENTER; MANAGEMENT; 1ST-LINE;
D O I
10.3748/wjg.v21.i9.2786
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To determine the resistance patterns of Heli-cobacter pylori (H. pylori) strains isolated from patients in Beijing and monitor the change of antibiotic resistance over time. METHODS: In this prospective, serial and cross-sectional study, H. pylori cultures were successfully obtained from 371 and 950 patients (never receiving eradication) during 2009-2010 and 2013-2014, respectively. Resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and rifampicin was determined by Epsilometer test. RESULTS: The resistance rates of isolates obtained during 2009-2010 were 66.8%, 39.9%, 34.5%, 15.4%, 6.7%, and 4.9% to metronidazole, clarithromycin, levofloxacin, rifampicin, amoxicillin and tetracycline, respectively; and the corresponding rates for isolates during 2013-2014 were 63.4%, 52.6%, 54.8%, 18.2%, 4.4% and 7.3%, respectively. The resistance rates to clarithromycin and levofloxacin were significantly increased after four years. In 2009-2010, 14.6% of H. pylori isolates were susceptible to all tested antibiotics, with mono (33.7%), double (28.3%), triple (16.7%), quadruple (6.2%), quintuple (0.3%) and sextuple resistance (0.3%) also being detected. In 2013-2014, 9.4% were susceptible to all tested antibiotics, and mono (27.6%), double (28.4%), triple (24.9%), quadruple (7.3%), quintuple (2.3%) and sextuple resistance (0.1%) was also observed. More multiple resistant H. pylori isolates were found during 2013-2014. Gender (to levofloxacin and metronidazole), age (to levofloxacin) and endoscopic findings (to clarithromycin) were independent factors influencing antibiotic resistance. CONCLUSION: H. pylori resistance to commonly used antibiotics in Beijing is high with increased multiple antibiotic resistance.
引用
收藏
页码:2786 / 2792
页数:7
相关论文
共 27 条
[1]
Cheng Hong, 2005, Zhonghua Yi Xue Za Zhi, V85, P2754
[2]
De Francesco Vincenzo, 2012, World J Gastrointest Pharmacol Ther, V3, P68, DOI 10.4292/wjgpt.v3.i4.68
[3]
Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[4]
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection [J].
Federico, Alessandro ;
Nardone, Gerardo ;
Gravina, Antonietta G. ;
Iovene, Maria Rosaria ;
Miranda, Agnese ;
Compare, Debora ;
Pilloni, Paola A. ;
Rocco, Alba ;
Ricciardiello, Luigi ;
Marmo, Riccardo ;
Loguercio, Carmelina ;
Romano, Marco .
GASTROENTEROLOGY, 2012, 143 (01) :55-U563
[5]
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection [J].
Fock, K. Ming ;
Katelaris, Peter ;
Sugano, Kentaro ;
Ang, Tiing Leong ;
Hunt, Richard ;
Talley, Nicholas J. ;
Lam, Shiu Kum ;
Xiao, Shu-Dong ;
Tan, Huck Joo ;
Wu, Chun-Ying ;
Jung, Hyun Chae ;
Bui Huu Hoang ;
Kachintorn, Udom ;
Goh, Khean-Lee ;
Chiba, Tsutomu ;
Rani, Abdul Aziz .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (10) :1587-1600
[6]
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection [J].
Furuta, Takahisa ;
Graham, David Y. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) :465-+
[7]
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy [J].
Gatta, Luigi ;
Vakil, Nimish ;
Vaira, Dino ;
Scarpignato, Carmelo .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[8]
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori [J].
Gisbert, Javier P. ;
Calvet, Xavier .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 :23-34
[9]
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States [J].
Graham, David Y. ;
Javed, Syed Ussama ;
Keihanian, Sara ;
Abudayyeh, Suhaib ;
Opekun, Antone R. .
JOURNAL OF GASTROENTEROLOGY, 2010, 45 (08) :816-820
[10]
Helicobacter pylori treatment in the era of increasing antibiotic resistance [J].
Graham, David Y. ;
Fischbach, Lori .
GUT, 2010, 59 (08) :1143-1153